121 related articles for article (PubMed ID: 19394683)
1. Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix.
Seppo A; Jalali GR; Babkowski R; Symiakaki H; Rodolakis A; Tafas T; Tsipouras P; Kilpatrick MW
Gynecol Oncol; 2009 Jul; 114(1):80-3. PubMed ID: 19394683
[TBL] [Abstract][Full Text] [Related]
2. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
Caraway NP; Khanna A; Dawlett M; Guo M; Guo N; Lin E; Katz RL
Gynecol Oncol; 2008 Jul; 110(1):37-42. PubMed ID: 18433848
[TBL] [Abstract][Full Text] [Related]
3. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.
Heselmeyer-Haddad K; Janz V; Castle PE; Chaudhri N; White N; Wilber K; Morrison LE; Auer G; Burroughs FH; Sherman ME; Ried T
Am J Pathol; 2003 Oct; 163(4):1405-16. PubMed ID: 14507648
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the 3q chromosomal region as a specific marker in cervical cancer.
Wright TC; Compagno J; Romano P; Grazioli V; Verma Y; Kershnar E; Tafas T; Kilpatrick MW
Am J Obstet Gynecol; 2015 Jul; 213(1):51.e1-51.e8. PubMed ID: 25659466
[TBL] [Abstract][Full Text] [Related]
5. Role of chromosome 3q26 gain in predicting progression of cervical dysplasia.
Rodolakis A; Biliatis I; Symiakaki H; Kershnar E; Kilpatrick MW; Haidopoulos D; Thomakos N; Antsaklis A
Int J Gynecol Cancer; 2012 Jun; 22(5):742-7. PubMed ID: 22635026
[TBL] [Abstract][Full Text] [Related]
6. Amplification of the chromosome 3q26 region shows high negative predictive value for nonmalignant transformation of LSIL cytologic finding.
Jalali GR; Herzog TJ; Dziura B; Walat R; Kilpatrick MW
Am J Obstet Gynecol; 2010 Jun; 202(6):581.e1-5. PubMed ID: 20171606
[TBL] [Abstract][Full Text] [Related]
7. Analysis of genetic copy number changes in cervical disease progression.
Policht FA; Song M; Sitailo S; O'Hare A; Ashfaq R; Muller CY; Morrison LE; King W; Sokolova IA
BMC Cancer; 2010 Aug; 10():432. PubMed ID: 20712890
[TBL] [Abstract][Full Text] [Related]
8. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
[TBL] [Abstract][Full Text] [Related]
9. Is there a gain in chromosome 3q in the pathway to anal cancer?
Ricciardi R; Burks E; Schoetz DJ; Verma Y; Kershnar E; Kilpatrick MW; Tsipouras P; Walat RJ
Dis Colon Rectum; 2014 Oct; 57(10):1183-7. PubMed ID: 25203374
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of genomic amplification of the human telomerase RNA component gene in the screening of cervical lesions].
Jiang J; Tu Z; Zhang G; Li JR; Zhao LJ; Zhao C; Cui SH; Li XP; Chen Z; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):849-53. PubMed ID: 19087570
[TBL] [Abstract][Full Text] [Related]
11. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
[TBL] [Abstract][Full Text] [Related]
12. Human telomerase RNA gene (TERC) gain and polysomy of chromosome 3 in cervicovaginal liquid-based pap preparations: a fluorescence in situ hybridization study.
Sui W; Ou M; Chen J; Yu J; Zhang Y; Lan H; Huang H; Dai Y
Eur J Gynaecol Oncol; 2010; 31(4):375-9. PubMed ID: 20882876
[TBL] [Abstract][Full Text] [Related]
13. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results.
Luhn P; Houldsworth J; Cahill L; Schiffman M; Castle PE; Zuna RE; Dunn ST; Gold MA; Walker J; Wentzensen N
Gynecol Oncol; 2013 Sep; 130(3):595-600. PubMed ID: 23769811
[TBL] [Abstract][Full Text] [Related]
15. Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.
Koeneman MM; Ovestad IT; Janssen EAM; Ummelen M; Kruitwagen RFPM; Hopman AH; Kruse AJ
Pathol Oncol Res; 2019 Apr; 25(2):549-557. PubMed ID: 30361910
[TBL] [Abstract][Full Text] [Related]
16. 3q26 amplification is an effective negative triage test for LSIL: a historical prospective study.
Heitmann ER; Lankachandra KM; Wall J; Harris GD; McKinney HJ; Jalali GR; Verma Y; Kershnar E; Kilpatrick MW; Tsipouras P; Harper DM
PLoS One; 2012; 7(7):e39101. PubMed ID: 22792164
[TBL] [Abstract][Full Text] [Related]
17. Cervical cytology by means of fluorescence in situ hybridization with a set of chromosome-specific DNA probes.
Hariu H; Matsuta M
J Obstet Gynaecol Res; 1996 Apr; 22(2):163-70. PubMed ID: 8697347
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions.
Zhang Y; Wang X; Ma L; Wang Z; Hu L
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):368-71. PubMed ID: 19513624
[TBL] [Abstract][Full Text] [Related]
19. Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression.
Marzano R; Corrado G; Merola R; Sbiroli C; Guadagni F; Vizza E; Del Nonno F; Carosi M; Galati M M; Sperduti I; Cianciulli AM
Eur J Cancer; 2004 Jul; 40(10):1624-9. PubMed ID: 15196550
[TBL] [Abstract][Full Text] [Related]
20. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
